Search research articles
Contact Us
Filters
Showing results (381-390 of 491) with videos related to
Page
of 50
Sort By:
Frontiers in Medicine
|
May 22, 2023
Evidence of the content validity, acceptability, and feasibility of a new Patient-Reported Impact of Dermatological Diseases measure
Rachael Pattinson, Nirohshah Trialonis-Suthakharan, Rachael M Hewitt, et al.
The British Journal of Dermatology
|
January 4, 2022
Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial
Matthias Augustin, Kristian Reich, Paul Yamauchi, et al.
Acta Dermato-Venereologica
|
March 6, 2025
Development and Validation of a Disease-specific Outcomes Tool for the Assessment of Patient Benefits of Treatment for Hidradenitis Suppurativa: the PBI-HS
Natalia Kirsten, Matthias Augustin, Christine Blome, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society
|
February 17, 2021
Assessing the quality of life of people with chronic wounds by using the cross-culturally valid and revised Wound-QoL questionnaire
Catharina C von Stülpnagel, Neuza da Silva, Matthias Augustin, et al.
Healthcare (Basel, Switzerland)
|
May 14, 2025
Communication and Therapy Planning for Patients of Reproductive Age Under Immunomodulatory Treatments for Psoriasis or Psoriatic Arthritis-Survey of the German National Psoriasis Registry PsoBest
Brigitte Stephan, Christina Sorbe, Birgit-Christiane Zyriax, et al.
Plos One
|
May 26, 2018
Willingness to pay for a cure of low-risk melanoma patients in Germany
Matthias Augustin, Christine Blome, Andrea Forschner, et al.
Journal of the American Academy of Dermatology
|
October 4, 2016
Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis
Steven R Feldman, Diamant Thaçi, Melinda Gooderham, et al.
Dermatology and Therapy
|
November 22, 2025
Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals
Raymond Matthews, April W Armstrong, Matthias Augustin, et al.
Journal of Clinical Medicine
|
July 13, 2024
Basic Susceptibility of Patients with Psoriasis under Systemic Therapy for Respiratory Infections: Data from the German Psoriasis Registry PsoBest
Brigitte Stephan, Stephan Jeff Rustenbach, Nesrine Ben-Anaya, et al.
Dermatology and Therapy
|
August 8, 2020
Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL)
Jean-Philippe Lacour, Anthony Bewley, Edward Hammond, et al.
Page
of 50
Search research articles
Search
Showing results (381-390 of 491) with videos related to
Sort By:
Page
of 50
Frontiers in Medicine
|
May 22, 2023
Evidence of the content validity, acceptability, and feasibility of a new Patient-Reported Impact of Dermatological Diseases measure
Rachael Pattinson, Nirohshah Trialonis-Suthakharan, Rachael M Hewitt, et al.
The British Journal of Dermatology
|
January 4, 2022
Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial
Matthias Augustin, Kristian Reich, Paul Yamauchi, et al.
Acta Dermato-Venereologica
|
March 6, 2025
Development and Validation of a Disease-specific Outcomes Tool for the Assessment of Patient Benefits of Treatment for Hidradenitis Suppurativa: the PBI-HS
Natalia Kirsten, Matthias Augustin, Christine Blome, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society
|
February 17, 2021
Assessing the quality of life of people with chronic wounds by using the cross-culturally valid and revised Wound-QoL questionnaire
Catharina C von Stülpnagel, Neuza da Silva, Matthias Augustin, et al.
Healthcare (Basel, Switzerland)
|
May 14, 2025
Communication and Therapy Planning for Patients of Reproductive Age Under Immunomodulatory Treatments for Psoriasis or Psoriatic Arthritis-Survey of the German National Psoriasis Registry PsoBest
Brigitte Stephan, Christina Sorbe, Birgit-Christiane Zyriax, et al.
Plos One
|
May 26, 2018
Willingness to pay for a cure of low-risk melanoma patients in Germany
Matthias Augustin, Christine Blome, Andrea Forschner, et al.
Journal of the American Academy of Dermatology
|
October 4, 2016
Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis
Steven R Feldman, Diamant Thaçi, Melinda Gooderham, et al.
Dermatology and Therapy
|
November 22, 2025
Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals
Raymond Matthews, April W Armstrong, Matthias Augustin, et al.
Journal of Clinical Medicine
|
July 13, 2024
Basic Susceptibility of Patients with Psoriasis under Systemic Therapy for Respiratory Infections: Data from the German Psoriasis Registry PsoBest
Brigitte Stephan, Stephan Jeff Rustenbach, Nesrine Ben-Anaya, et al.
Dermatology and Therapy
|
August 8, 2020
Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL)
Jean-Philippe Lacour, Anthony Bewley, Edward Hammond, et al.
Page
of 50